HDAC1 and neoplasm: In renal carcinoma, CBX4 interacts with histone deacetylase 1 (HDAC1) to suppress the transcriptional activity of the Kruppel-like factor 6 (KLF6) promoter, leading to reduced KLF6 expression and tumor-promoting effects [26].